AZ Taps Swedish Roots For Novel Protein Research
This article was originally published in Scrip
Executive Summary
AstraZeneca PLC is tapping its Swedish roots with a groundbreaking collaboration aimed at exploring the potential of an emerging class of proteins using the newly mapped Secretome for new drug development.